These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36651841)

  • 1. A case of schizophrenia with relapsed catatonia successfully treated with blonanserin transdermal patch.
    Hagikura M; Inada T
    Neuropsychopharmacol Rep; 2023 Mar; 43(1):150-153. PubMed ID: 36651841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics].
    Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ
    Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching from blonanserin oral tablets/powders to transdermal patches alleviates extrapyramidal symptoms in patients with schizophrenia: A 52-week open-label study.
    Ohi K; Takai K; Kuramitsu A; Sugiyama S; Shioiri T
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110470. PubMed ID: 34740708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.
    Iwata N; Ishigooka J; Naoi I; Matsumoto M; Kanamori Y; Nakamura H; Higuchi T
    CNS Drugs; 2020 Jan; 34(1):103-116. PubMed ID: 31883082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Catatonia de novo, report on a case: immediate vital prognosis and psychiatric prognosis in longer term].
    Patry L; Guillem E; Pontonnier F; Ferreri M
    Encephale; 2003; 29(1):72-9. PubMed ID: 12640330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catatonia and its treatment.
    Rosebush PI; Mazurek MF
    Schizophr Bull; 2010 Mar; 36(2):239-42. PubMed ID: 19969591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy.
    Häßler F; Reis O; Weirich S; Höppner J; Pohl B; Buchmann J
    Z Kinder Jugendpsychiatr Psychother; 2013 Jan; 41(1):69-74. PubMed ID: 23258439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal Dopamine D2 Receptor Occupancy Induced by Daily Application of Blonanserin Transdermal Patches: Phase II Study in Japanese Patients With Schizophrenia.
    Nishibe H; Tateno A; Sakayori T; Yamamoto M; Kim W; Kakuyama H; Okubo Y
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):108-117. PubMed ID: 32936897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic Evaluation of Blonanserin Transdermal Patch: Population Analysis and Simulation of Plasma Concentration and Dopamine D
    Kitamura A; Takagaki T; Nemoto D; Tomita Y; Nishibe H; Kakuyama H
    J Clin Pharmacol; 2021 Aug; 61(8):1069-1080. PubMed ID: 33599975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Schizophrenia With Catatonia Resistant to Lorazepam and Olanzapine Monotherapy But Responsive to Combination Treatment: Is It Time to Consider Using Select Second-Generation Antipsychotics Earlier in the Treatment Algorithm for This Patient Type?
    Spiegel DR; Glad R; Smith M; Raja U; Wade R; Johnson K
    Clin Neuropharmacol; 2019; 42(2):57-59. PubMed ID: 30762605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy.
    Bai Y; Yang X; Zeng Z; Yang H
    BMC Psychiatry; 2018 Mar; 18(1):67. PubMed ID: 29534691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catatonia: resurgence of a concept. A review of the international literature].
    Pommepuy N; Januel D
    Encephale; 2002; 28(6 Pt 1):481-92. PubMed ID: 12506260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
    Huang MW; Gibson RC; Jayaram MB; Caroff SN
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013100. PubMed ID: 35844143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report.
    Sakai S; Morimoto Y; Matsuzaka Y; Nakano T; Kanegae S; Imamura A; Ozawa H
    Neuropsychopharmacol Rep; 2021 Sep; 41(3):440-443. PubMed ID: 34357702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodic catatonia with long-term treatment: a case report.
    Chen RA; Huang TL
    BMC Psychiatry; 2017 Sep; 17(1):337. PubMed ID: 28962597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses.
    Zaman H; Gibson RC; Walcott G
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD006570. PubMed ID: 31425609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine in schizophrenia patients with recurrent catatonia: report of two cases.
    Hung YY; Yang PS; Huang TL
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):256-8. PubMed ID: 16594953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.